Clinical Trial Update: Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1 [Phase 2]

View source ↗

Summary

Phase 2 trial updates the efficacy and safety of an all-oral combo (narlaprevir/ritonavir + sofosbuvir) in treatment-naïve chronic hepatitis C genotype 1 patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Narlaprevir/Ritonavir and Sofosbuvir (narlaprevir/ritonavir plus sofosbuvir)

Snippet

Sponsor: R-Pharm | Conditions: Chronic Hepatitis c Genotype 1 | Phase 2 | Status: COMPLETED